1. COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital,
2. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, and
3. Department of Food Science, University of Copenhagen, Frederiksberg, Denmark;
4. Section of Microbiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark;
5. Novozymes, Bagsvaerd, Denmark;
6. National Heart and Lung Institute, Imperial College, London, United Kingdom;
7. Department of Respiratory Paediatrics, Royal Brompton Hospital, London, United Kingdom;
8. Clinical and Experimental Sciences, and
9. Human Development and Health, Faculty of Medicine, University of Southampton, United Kingdom;
10. NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom;
11. Pediatric Respiratory Medicine, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;
12. University Children’s Hospital (UKBB), University of Basel, Basel, Switzerland;
13. Karolinska Institutet, Department of Women’s and Children’s Health and Astrid Lindgren Children’s Hospital, Stockholm, Sweden;
14. Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom;
15. NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom;
16. Department of Respiratory Medicine, Amsterdam UMC and
17. Department of Paediatric Respiratory Medicine and Allergy, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands;
18. Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom;
19. Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, London, United Kingdom;
20. NIHR Imperial Biomedical Research Centre, London, United Kingdom;
21. European Institute for Systems Biology and Medicine, Vourles, France;
22. Acclarogen Ltd, Cambridge, United Kingdom; and
23. BioSci Consulting, Maasmechelen, Belgium